Ozlem Yesil-Celiktas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ozlem Yesil-Celiktas has a total of 269 co-authors. Here are the top co-authors by number of shared publications:
Pelin Saglam-Metiner
Translational Pulmonary Research Center (EgeSAM), Ege University Faculty of Medicine, İzmir, Türkiye
14 shared publications- Aslihan Kazan
Department of Bioengineering, Faculty of Engineering and Natural Sciences, Bursa Technical University, Bursa, Turkey
11 shared publications Ece Yildiz-Ozturk
Department of Food Processing Food Technology Programme Yasar University Izmir Türkiye
11 shared publications- Pelin Saglam-Metiner
Department of Bioengineering Faculty of Engineering Ege University Izmir Turkiye
8 shared publications Sayit Sargin
8 shared publicationsCanan Sevimli-Gur
Department of Biology, Biotechnology Discipline, Science and Art Faculty, Kocaeli University, 41380 Izmit, Kocaeli, Turkey
6 shared publications
Latest Publications
- 19 September 2026
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 269
Nanoparticle-lipid interactions and their roles in nano-bio interface dynamics
- 19 September 2026
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 269
Nanoparticle-lipid interactions and their roles in nano-bio interface dynamics
- Open Access
- 8 July 2026
- Published by Wiley in Macromolecular Materials and Engineering
- Vol. 311 (7) , e70274
Engineering a Lung‐Derived Extracellular Matrix‐GelMA Hydrogel to Elucidate Alterations in Lung Tumor‐Stroma‐On‐Chip
Lung cancer progression is regulated by dynamic alterations in the extracellular matrix (ECM), yet these changes remain insufficiently captured in conventional in vitro models. Here, we present a biomimetic lung tumor‐stroma‐on‐chip integrating a decellularized lung‐derived ECM (dlECM) with gelatin methacrylate (GelMA) hydrogel to recapitulate tissue‐specific microenvironmental dynamics. The decellularization protocol was optimized to achieve approximately 98%–99% DNA removal, while maintaining the integrity of key ECM components including ∼70% collagen, ∼62% elastin, and near‐complete retention of sGAGs, ensuring biochemical fidelity. The hybrid GelMA‐dlECM hydrogel was engineered to support a multicellular architecture, where lung carcinoma cells formed a central tumor focus, surrounded by fibroblasts and overlaid with epithelial cells, emulating the lung tumor microenvironment. Mechanical characterization revealed an increase in matrix stiffness in the tumor model (154.7 Pa) compared to the healthy one (108.29 Pa), accompanied by elevated collagen and elastin deposition, indicating cancer‐associated matrix remodeling. Consistent with these findings, MMP‐2 and MMP‐9 levels were markedly upregulated at early time points, reflecting active ECM degradation and remodeling processes. Collectively, this platform demonstrates how the interplay between biochemical composition and mechanical properties governs tumor evolution, providing a physiologically relevant model for investigating ECM‐driven mechanisms in lung cancer and for future therapeutic screening applications.
- 8 July 2026
- Published by Wiley in Macromolecular Materials and Engineering
- Vol. 311 (7) , e70274
Open AccessEngineering a Lung‐Derived Extracellular Matrix‐GelMA Hydrogel to Elucidate Alterations in Lung Tumor‐Stroma‐On‐Chip
Lung cancer progression is regulated by dynamic alterations in the extracellular matrix (ECM), yet these changes remain insufficiently captured in conventional in vitro models. Here, we present a biomimetic lung tumor‐stroma‐on‐chip integrating a decellularized lung‐derived ECM (dlECM) with gelatin methacrylate (GelMA) hydrogel to recapitulate tissue‐specific microenvironmental dynamics. The decellularization protocol was optimized to achieve approximately 98%–99% DNA removal, while maintaining the integrity of key ECM components including ∼70% collagen, ∼62% elastin, and near‐complete retention of sGAGs, ensuring biochemical fidelity. The hybrid GelMA‐dlECM hydrogel was engineered to support a multicellular architecture, where lung carcinoma cells formed a central tumor focus, surrounded by fibroblasts and overlaid with epithelial cells, emulating the lung tumor microenvironment. Mechanical characterization revealed an increase in matrix stiffness in the tumor model (154.7 Pa) compared to the healthy one (108.29 Pa), accompanied by elevated collagen and elastin deposition, indicating cancer‐associated matrix remodeling. Consistent with these findings, MMP‐2 and MMP‐9 levels were markedly upregulated at early time points, reflecting active ECM degradation and remodeling processes. Collectively, this platform demonstrates how the interplay between biochemical composition and mechanical properties governs tumor evolution, providing a physiologically relevant model for investigating ECM‐driven mechanisms in lung cancer and for future therapeutic screening applications.
- 7 July 2026
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (28) , e05937
Microfluidic Biofabrication of a Hydrogel Vessel‐Like Structure for Interrogating Tumor Cell Propagation in a Breast Cancer‐on‐a‐Chip Model
Engineering physiologically relevant vascular models remains a challenge in cancer biology and tissue engineering. Here, we present a microfluidic wet‐spinning methodology for the biofabrication of cell‐laden alginate‐gelatin methacryloyl (GelMA) hydrogel‐based vessel‐like structures with controlled geometry and perfusable architecture. Using a sacrificial gelatin core within a core–shell microfluidic device, tubular scaffolds were produced in a single continuous step under mild, cell‐compatible conditions. The alginate‐GelMA shell is fine‐tuned and loaded with human umbilical vein endothelial cells (HUVEC), yielding an endothelialized‐like, perfusable construct at the small‐vein scale (∼0.6–0.7 mm lumen diameter). As a proof‐of‐concept use case, the biofabricated vessel‐like structure was integrated into the breast cancer‐on‐a‐chip (BCoC) platform to showcase its feasibility in a 3D vascularized‐like tumor model for interrogating cancer cell propagation. Breast cancer spheroids were positioned in the surrounding GelMA matrix (perivascular‐like compartment), and THP‐1 monocytes were circulated through the perfusion platform. Cancer cell dissemination, quantified as circulating tumor cells (CTCs), was modulated by the immune microenvironment: interleukin‐4 (IL‐4, anti‐inflammatory‐like) conditions promoted peak CTC release, whereas lipopolysaccharide (LPS, pro‐inflammatory‐like) stimulation suppressed this dissemination. Our model integrates the vascular, tumor, and immune compartments within a single construct, providing a versatile platform for investigations of breast cancer dissemination and tumor‐immune crosstalk.
- 7 July 2026
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (28) , e05937
Microfluidic Biofabrication of a Hydrogel Vessel‐Like Structure for Interrogating Tumor Cell Propagation in a Breast Cancer‐on‐a‐Chip Model
Engineering physiologically relevant vascular models remains a challenge in cancer biology and tissue engineering. Here, we present a microfluidic wet‐spinning methodology for the biofabrication of cell‐laden alginate‐gelatin methacryloyl (GelMA) hydrogel‐based vessel‐like structures with controlled geometry and perfusable architecture. Using a sacrificial gelatin core within a core–shell microfluidic device, tubular scaffolds were produced in a single continuous step under mild, cell‐compatible conditions. The alginate‐GelMA shell is fine‐tuned and loaded with human umbilical vein endothelial cells (HUVEC), yielding an endothelialized‐like, perfusable construct at the small‐vein scale (∼0.6–0.7 mm lumen diameter). As a proof‐of‐concept use case, the biofabricated vessel‐like structure was integrated into the breast cancer‐on‐a‐chip (BCoC) platform to showcase its feasibility in a 3D vascularized‐like tumor model for interrogating cancer cell propagation. Breast cancer spheroids were positioned in the surrounding GelMA matrix (perivascular‐like compartment), and THP‐1 monocytes were circulated through the perfusion platform. Cancer cell dissemination, quantified as circulating tumor cells (CTCs), was modulated by the immune microenvironment: interleukin‐4 (IL‐4, anti‐inflammatory‐like) conditions promoted peak CTC release, whereas lipopolysaccharide (LPS, pro‐inflammatory‐like) stimulation suppressed this dissemination. Our model integrates the vascular, tumor, and immune compartments within a single construct, providing a versatile platform for investigations of breast cancer dissemination and tumor‐immune crosstalk.
- Open Access
- 14 April 2026
- Published by Galenos Yayinevi in Thoracic Research and Practice
- Vol. 27 (3) , 182-194
The Impact of the Exposome on Epithelial Barriers: New Approach Methodologies for Translational Research
The Impact of the Exposome on Epithelial Barriers: New Approach Methodologies for Translational Research - Thoracic Research and Practice
- 14 April 2026
- Published by Galenos Yayinevi in Thoracic Research and Practice
- Vol. 27 (3) , 182-194
Open AccessThe Impact of the Exposome on Epithelial Barriers: New Approach Methodologies for Translational Research
The Impact of the Exposome on Epithelial Barriers: New Approach Methodologies for Translational Research - Thoracic Research and Practice
- Open Access
Polypropylene Nanoplastic Exposure to Respiratory Epithelial Barrier‐On‐Chip and Interfacial Interactions With Human Serum Albumin
Under the influence of environmental pollution, chronic non‐communicable diseases have increased. The epithelial lining of the airway forms the initial barrier; however, upon exposure, nanoplastics (NPs) may cross this interface and enter systemic circulation. This study aims to elucidate the effects of polypropylene nanoplastics (PP NPs) on the epithelial barrier and the interactions with serum proteins. PP beads were chemically degraded, characterized, and administered to the epithelial barrier‐on‐chip at a dose of 250 μg/mL, followed by continuous perfusion for 3 days. Their colloidal and biological behavior was investigated in cell culture medium supplemented with 10% fetal bovine serum. To explore clinical relevance, the interaction of PP NPs with human serum albumin was analyzed using molecular dynamics simulations, supported by protein profiling of plasma samples from healthy male and female individuals to understand gender‐related differences. PP NPs with an average size of 305 nm were exposed to the epithelial barrier‐on‐chip leading to a decrease in cell viability via apoptotic cell death and transepithelial electrical resistance (TEER) value from ~2600 to 2200 Ω·cm 2 with altered ZO‐1 and ACE2 expression, as well as an increased proinflammatory response and intracellular reactive oxygen species (ROS) levels. [Correction added on 15 April 2026, after first online publication: The word “suppressed” has been deleted from the ] The size of NPs increased to 364 nm after incubation with cell culture medium, indicating protein corona formation. The simulation revealed a biphasic adsorption pattern. The major differences in blood plasma of male and female donors were observed in the protein bands around 130 and 180 kDa. By integrating experimental and computational approaches, this study advances our understanding of how inhaled NPs may interact with blood proteins upon systemic exposure, with potential implications for human health risk assessment.
Open AccessPolypropylene Nanoplastic Exposure to Respiratory Epithelial Barrier‐On‐Chip and Interfacial Interactions With Human Serum Albumin
Under the influence of environmental pollution, chronic non‐communicable diseases have increased. The epithelial lining of the airway forms the initial barrier; however, upon exposure, nanoplastics (NPs) may cross this interface and enter systemic circulation. This study aims to elucidate the effects of polypropylene nanoplastics (PP NPs) on the epithelial barrier and the interactions with serum proteins. PP beads were chemically degraded, characterized, and administered to the epithelial barrier‐on‐chip at a dose of 250 μg/mL, followed by continuous perfusion for 3 days. Their colloidal and biological behavior was investigated in cell culture medium supplemented with 10% fetal bovine serum. To explore clinical relevance, the interaction of PP NPs with human serum albumin was analyzed using molecular dynamics simulations, supported by protein profiling of plasma samples from healthy male and female individuals to understand gender‐related differences. PP NPs with an average size of 305 nm were exposed to the epithelial barrier‐on‐chip leading to a decrease in cell viability via apoptotic cell death and transepithelial electrical resistance (TEER) value from ~2600 to 2200 Ω·cm 2 with altered ZO‐1 and ACE2 expression, as well as an increased proinflammatory response and intracellular reactive oxygen species (ROS) levels. [Correction added on 15 April 2026, after first online publication: The word “suppressed” has been deleted from the ] The size of NPs increased to 364 nm after incubation with cell culture medium, indicating protein corona formation. The simulation revealed a biphasic adsorption pattern. The major differences in blood plasma of male and female donors were observed in the protein bands around 130 and 180 kDa. By integrating experimental and computational approaches, this study advances our understanding of how inhaled NPs may interact with blood proteins upon systemic exposure, with potential implications for human health risk assessment.
- Open Access
- 21 January 2026
- Published by Elsevier in Biosensors and Bioelectronics: X
- Vol. 29
Synthesis of an electrically conductive film and stimulation of neurons in a microfluidic platform integrated with ITO-coated PET electrodes
- 21 January 2026
- Published by Elsevier in Biosensors and Bioelectronics: X
- Vol. 29
Open AccessSynthesis of an electrically conductive film and stimulation of neurons in a microfluidic platform integrated with ITO-coated PET electrodes
- Open Access
- 30 December 2025
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
A perfusable decellularized plant-based air-liquid-interface-on-a-chip for investigating inorganic dust aerosol exposure
Dust exposure affects an estimated 330 million people worldwide and can penetrate deep into the respiratory tract, disrupting epithelial and endothelial barriers. However, current in vitro models do not recapitulate the perfusable airway-vascular interface required to investigate dust-induced barrier alterations. Bioinspired scaffolds from decellularized plants hold strong potential as new approach methodologies (NAMs), considering the need for physiologically relevant in vitro models with vascular networks. Herein, we developed a decellularized plant-based air–liquid interface (ALI)-on-a-chip to study inorganic dust aerosol exposure in human airway epithelial barrier. The decellularization method achieved ≥ 99% DNA removal and a hydrophilic interface, while preserving vascular network and cellulose-rich extracellular matrix. Subsequently, human umbilical vein endothelial cells and bronchial epithelial cells were seeded to the decellularized scaffold, positioned on a PDMS-based platform to reconstruct a perfusable ALI-on-a-chip. Nanoscale dust particles were administered to the epithelium. The dust particles resulted in a significant decrease in barrier integrity, where the TEER value of the epithelial barrier decreased from ~ 126.42 to ~ 56.11Ω*cm2, with altered cell viabilities, and significant increases in pro-inflammatory cytokines such as TNF-α and IL-6. Our study reports the effects of inhaled dust aerosols on pulmonary barriers, along with offering a plant-based, biocompatible, and tissue-emulating air–liquid interface on-a-chip model. The developed model offers a versatile platform for studying toxicity of diverse particles and a preclinical evaluation of respiratory therapeutics.
- 30 December 2025
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessA perfusable decellularized plant-based air-liquid-interface-on-a-chip for investigating inorganic dust aerosol exposure
Dust exposure affects an estimated 330 million people worldwide and can penetrate deep into the respiratory tract, disrupting epithelial and endothelial barriers. However, current in vitro models do not recapitulate the perfusable airway-vascular interface required to investigate dust-induced barrier alterations. Bioinspired scaffolds from decellularized plants hold strong potential as new approach methodologies (NAMs), considering the need for physiologically relevant in vitro models with vascular networks. Herein, we developed a decellularized plant-based air–liquid interface (ALI)-on-a-chip to study inorganic dust aerosol exposure in human airway epithelial barrier. The decellularization method achieved ≥ 99% DNA removal and a hydrophilic interface, while preserving vascular network and cellulose-rich extracellular matrix. Subsequently, human umbilical vein endothelial cells and bronchial epithelial cells were seeded to the decellularized scaffold, positioned on a PDMS-based platform to reconstruct a perfusable ALI-on-a-chip. Nanoscale dust particles were administered to the epithelium. The dust particles resulted in a significant decrease in barrier integrity, where the TEER value of the epithelial barrier decreased from ~ 126.42 to ~ 56.11Ω*cm2, with altered cell viabilities, and significant increases in pro-inflammatory cytokines such as TNF-α and IL-6. Our study reports the effects of inhaled dust aerosols on pulmonary barriers, along with offering a plant-based, biocompatible, and tissue-emulating air–liquid interface on-a-chip model. The developed model offers a versatile platform for studying toxicity of diverse particles and a preclinical evaluation of respiratory therapeutics.
- Open Access
- 1 December 2025
- Published by Galenos Yayinevi in Thoracic Research and Practice
- Vol. 26 (Suppl 1) , 10-11
Hydrogel Formulations to Investigate Lung Cancer Mechanism
Hydrogel Formulations to Investigate Lung Cancer Mechanism - Thoracic Research and Practice
- 1 December 2025
- Published by Galenos Yayinevi in Thoracic Research and Practice
- Vol. 26 (Suppl 1) , 10-11
Open AccessHydrogel Formulations to Investigate Lung Cancer Mechanism
Hydrogel Formulations to Investigate Lung Cancer Mechanism - Thoracic Research and Practice
- Open Access
- 1 December 2025
- Published by Galenos Yayinevi in Thoracic Research and Practice
- Vol. 26 (Suppl 1) , 4-6
A NAMs-Based Microphysiological System for Metastasis and Mechanobiology Studies
A NAMs-Based Microphysiological System for Metastasis and Mechanobiology Studies - Thoracic Research and Practice
- 1 December 2025
- Published by Galenos Yayinevi in Thoracic Research and Practice
- Vol. 26 (Suppl 1) , 4-6
Open AccessA NAMs-Based Microphysiological System for Metastasis and Mechanobiology Studies
A NAMs-Based Microphysiological System for Metastasis and Mechanobiology Studies - Thoracic Research and Practice
- Open Access
- 1 December 2025
- Published by Galenos Yayinevi in Thoracic Research and Practice
- Vol. 26 (Suppl 1) , 7-9
Occupational and Environmental Exposures: Trends in Publications, Diseases, and Experimental Models
Occupational and Environmental Exposures: Trends in Publications, Diseases, and Experimental Models - Thoracic Research and Practice
- 1 December 2025
- Published by Galenos Yayinevi in Thoracic Research and Practice
- Vol. 26 (Suppl 1) , 7-9
Open AccessOccupational and Environmental Exposures: Trends in Publications, Diseases, and Experimental Models
Occupational and Environmental Exposures: Trends in Publications, Diseases, and Experimental Models - Thoracic Research and Practice